Sumayang, Nolasco L.
HRN: 24-37-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2024
CEFTRIAXONE 1G (VIAL)
01/14/2024
01/21/2024
IV
2g
Q24
Cellulitis Left Leg; R/O PAOD
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes